Other insiders active in the same sector
No other insider has filed at Michael D. Kishbauch's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
- Mayukh Sukhatme - $109.13M in ROIV purchases and sales in the last 12 months
- Emily M. Leproust - $101.55M in TWST purchases and sales in the last 12 months
- Bruce Booth - $100.59M in KYMR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael D. Kishbauch?
Michael D. Kishbauch is a corporate insider of Astria Therapeutics, Inc. (ATXS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael D. Kishbauch last file a Form 4?
The most recent primary Form 4 on record is dated 23 January 2026, one of 2 filings going back to 2025.